Centre Hospitalier de la côte Basque

Bayonne, Pyrenees-Atlantiques 64109

0 studies enrolling now · 4 studies all time

What they study most

Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Breast Cancer, First Line Non-Small Cell Lung Cancer, Lung Adenocarcinoma Stage IIIB/IV, Solid Tumor

Studies at this site

• A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types — Recruiting now
• Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION) — Running, not enrolling
• DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02] — Completed
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed